JORGE BAUTISTA: Open Payments
NPI 1336254705 · FILLMORE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,152 in 101 payments from 11 companies in 2025. Trend: 2023 $774 · 2024 $1,477 · 2025 $2,152
Food & beverage: $2,152
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $542 |
| Amgen Inc. | 23 | $507 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $256 |
| Novo Nordisk Inc | 15 | $247 |
| Otsuka America Pharmaceutical, Inc. | 13 | $171 |
| Exact Sciences Corporation | 9 | $157 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $96 |
| Kowa Pharmaceuticals America, Inc. | 4 | $74 |
| Lilly USA, LLC | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $41 |
Products named: BREZTRI, OTEZLA, JARDIANCE, REPATHA, REXULTI, Ozempic, Cologuard Collection Kit, Kerendia.
Industry payments across CA — which companies pay providers there.
